The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
The precision prevention and therapy of HPV‐related cervical cancer: new concepts and clinical implications
Open accessAbstract
Cervical cancer is the third most common cancer in women worldwide, with concepts and knowledge about its prevention and treatment evolving rapidly. Human papillomavirus (HPV) has been identified as a major factor that leads to cervical cancer, although HPV infection alone cannot cause the disease. In fact, HPV‐driven cancer is a small probability event because most infections are transient and could be cleared spontaneously by host immune system. With persistent HPV infection, decades are required for progression to cervical cancer. Therefore, this long time window provides golden opportunity for clinical intervention, and the fundament here is to elucidate the carcinogenic pattern and applicable targets during HPV‐host interaction. In this review, we discuss the key factors that contribute to the persistence of HPV and cervical carcinogenesis, emerging new concepts and technologies for cancer interventions, and more urgently, how these concepts and technologies might lead to clinical precision medicine which could provide prediction, prevention, and early treatment for patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
Papillomaviruses and cancer: from basic studies to clinical application
zur Hausen, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc798 · Cited by 4,024
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292 · cited 1×
“The relatively short length of the CRISPR recognition sequence (approximately 14 nucleotides) makes the endonuclease more prone to produce undesired, off- target mutations in the human genome, thus limiting its further use in therapeutic applications [189].”
BackgroundClassification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Human papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Global burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,635
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Tewari, K. S., Sill, M. W., Long, H. J., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309748 · Cited by 1,504
Integrated genomic and molecular characterization of cervical cancer
The Cancer Genome Atlas Research Network (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,479
HPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,321
Human papillomavirus and cervical cancer
Crosbie, E. J., Einstein, M. H., Franceschi, S., & Kitchener, H. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60022-7 · Cited by 1,171
The natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
Landscape of genomic alterations in cervical carcinomas
Ojesina, A. I., Lichtenstein, L., Freeman, S. S., Pedamallu, C. S., Imaz-Rosshandler, I., Pugh, T. J., Cherniack, A. D., Ambrogio, L., Cibulskis, K., Bertelsen, B., et al. (2014) · Nature · doi:10.1038/nature12881 · Cited by 867
Hernandez, P. A., Gorlin, R. J., Lukens, J. N., Taniuchi, S., Bohinjec, J., Francois, F., Klotman, M. E., & Diaz, G. A. (2003) · Nature Genetics · doi:10.1038/ng1149 · Cited by 722 · cited 1×
“Obvious evidence of genetic factors contributing to cervical carcinogenesis can be proved by warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome (WHIM) and hereditary nonpolyposis colorectal cancer (Lynch) syndrome, two autosomal dominant genetic disorder characterized by extensive HPV infection…”
BackgroundSalazar, K. L., Zhou, H. S., Xu, J., Peterson, L. E., Schwartz, M. R., Mody, D. R., & Ge, Y. (2015) · Acta Cytologica · doi:10.1159/000442512 · Cited by 721
The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States
Chesson, H. W., Dunne, E. F., Hariri, S., & Markowitz, L. E. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000193 · Cited by 706
Stevanović, S., Draper, L. M., Langhan, M. M., Campbell, T. E., Kwong, M. L., Wunderlich, J. R., Dudley, M. E., Yang, J. C., Sherry, R. M., Kammula, U. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.9093 · Cited by 682
Preparing for Precision Medicine
Mirnezami, R., Nicholson, J., & Darzi, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1114866 · Cited by 663
Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., & Wright, T. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.11.076 · Cited by 592
Hu, Z., Zhu, D., Wang, W., Li, W., Jia, W., Zeng, X., Ding, W., Yu, L., Wang, X., Wang, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3178 · Cited by 565
Self-citationKleter, B., van Doorn, L.-J., ter Schegget, J., Schrauwen, L., van Krimpen, K., Burger, M., ter Harmsel, B., & Quint, W. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65688-x · Cited by 509
(2012) · PubMed Central · Cited by 502
Wright, T. C., Schiffman, M., Solomon, D., Cox, J. T., Garcia, F., Goldie, S., Hatch, K., Noller, K. L., Roach, N., Runowicz, C., et al. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000109426.82624.f8 · Cited by 499
Human papillomavirus genome variants
Burk, R. D., Harari, A., & Chen, Z. (2013) · Virology · doi:10.1016/j.virol.2013.07.018 · Cited by 484
Bernard, H.-U., Chan, S.-Y., Manos, M. M., Ong, C.-K., Villa, L. L., Delius, H., Peyton, C. L., Bauer, H. M., & Wheeler, C. M. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1077 · Cited by 479
The 1988 Bethesda System for Reporting Cervical/Vaginal Cytological Diagnoses
(1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430070079034 · Cited by 474
Akagi, K., Li, J., Broutian, T. R., Padilla-Nash, H., Xiao, W., Jiang, B., Rocco, J. W., Teknos, T. N., Kumar, B., Wangsa, D., et al. (2014) · Genome Research · doi:10.1101/gr.164806.113 · Cited by 468
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Pett, M., & Coleman, N. (2007) · The Journal of Pathology · doi:10.1002/path.2192 · Cited by 451
Regression of low-grade squamous intra-epithelial lesions in young women
Moscicki, A.-B., Shiboski, S., Hills, N. K., Powell, K. J., Jay, N., Hanson, E. N., Miller, S., Canjura-Clayton, L. K., Farhat, S., Broering, J. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17354-6 · Cited by 448
The growing burden of cancer in India: epidemiology and social context
Mallath, M. K., Taylor, D. G., Badwe, R. A., Rath, G. K., Shanta, V, Pramesh, C. S., Digumarti, R., Sebastian, P., Borthakur, B. B., Kalwar, A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70115-9 · Cited by 447
Klaes, R., Woerner, S. M., Ridder, R., Wentzensen, N., Duerst, M., Schneider, A., Lotz, B., Melsheimer, P., & Doeberitz, M. V. K. (1999) · PubMed · Cited by 407
Wentzensen, N., Vinokurova, S., & Doeberitz, M. V. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0009 · Cited by 368
The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line
Adey, A., Burton, J. N., Kitzman, J. O., Hiatt, J. B., Lewis, A. P., Martin, B. K., Qiu, R., Lee, C., & Shendure, J. (2013) · Nature · doi:10.1038/nature12064 · Cited by 362
Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia
Trottier, H., Mahmud, S., Costa, M. C., Sobrinho, J. P., Duarte-Franco, E., Rohan, T. E., Ferenczy, A., Villa, L. L., & Franco, E. L. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0129 · Cited by 352
Triage of HPV positive women in cervical cancer screening
Wentzensen, N., Schiffman, M., Palmer, T., & Arbyn, M. (2016) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.11.015 · Cited by 347
High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology
Stoler, M. H., Wright, T. C., Sharma, A., Apple, R., Gutekunst, K., & Wright, T. L. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpz5jy6fcvnmot · Cited by 330
Practice Bulletin No. 131: Screening for Cervical Cancer
(2012) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318277c92a · Cited by 298
HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis
Mirabello, L., Yeager, M., Yu, K., Clifford, G. M., Xiao, Y., Zhu, B., Cullen, M., Boland, J. F., Wentzensen, N., Nelson, C. W., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.001 · Cited by 289
Huh, W. K., Ault, K. A., Chelmow, D., Davey, D. D., Goulart, R. A., Garcia, F. A. R., Kinney, W. K., Massad, L. S., Mayeaux, E. J., Saslow, D., et al. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000669 · Cited by 280
A review of methods for detect human Papillomavirusinfection
Abreu, A. L. P., Souza, R. P., Gimenes, F., & Consolaro, M. E. L. (2012) · Virology Journal · doi:10.1186/1743-422x-9-262 · Cited by 275
Wright, A. A., Howitt, B. E., Myers, A. P., Dahlberg, S. E., Palescandolo, E., Van Hummelen, P., MacConaill, L. E., Shoni, M., Wagle, N., Jones, R. T., et al. (2013) · Cancer · doi:10.1002/cncr.28288 · Cited by 274
The diagnostic value of vaginal smears in carcinoma of the uterus. 1941.
Papanicolaou, G. N., & Traut, H. F. (1997) · PubMed · Cited by 273
Mucoadhesive and thermogelling systems for vaginal drug delivery
Caramella, C. M., Rossi, S., Ferrari, F., Bonferoni, M. C., & Sandri, G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.02.001 · Cited by 264
Burden of cervical cancer and role of screening in India
Bobdey, S., Sathwara, J., Jain, A., & Balasubramaniam, G. (2016) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.195751 · Cited by 254
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors
Thorland, E. C., Myers, S. L., Gostout, B. S., & Smith, D. I. (2003) · Oncogene · doi:10.1038/sj.onc.1206170 · Cited by 248
PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
Janku, F., Lee, J. J., Tsimberidou, A. M., Hong, D. S., Naing, A., Falchook, G. S., Fu, S., Luthra, R., Garrido-Laguna, I., & Kurzrock, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022769 · Cited by 204
Crow, J. M. (2012) · Nature · doi:10.1038/488s2a · Cited by 203
Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes
Heideman, D. A. M., Hesselink, A. T., Berkhof, J., van Kemenade, F., Melchers, W. J. G., Daalmeijer, N. F., Verkuijten, M., Meijer, C. J. L. M., & Snijders, P. J. F. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05552-11 · Cited by 201
Mirabello, L., Yeager, M., Cullen, M., Boland, J. F., Chen, Z., Wentzensen, N., Zhang, X., Yu, K., Yang, Q., Mitchell, J., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw100 · Cited by 201
Wang, Q., Jia, P., & Zhao, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064465 · Cited by 185
Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer
Clarke, M. A., Wentzensen, N., Mirabello, L., Ghosh, A., Wacholder, S., Harari, A., Lorincz, A., Schiffman, M., & Burk, R. D. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0905 · Cited by 183
Genome-wide Association Study of Susceptibility Loci for Cervical Cancer
Chen, D., Juko-Pecirep, I., Hammer, J., Ivansson, E., Enroth, S., Gustavsson, I., Feuk, L., Magnusson, P. K. E., McKay, J. D., Wilander, E., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt051 · Cited by 180
Cervical cancer screening in Europe: Quality assurance and organisation of programmes
Elfström, K. M., Arnheim-Dahlström, L., von Karsa, L., & Dillner, J. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.03.008 · Cited by 176
Ziegert, C., Wentzensen, N., Vinokurova, S., Kisseljov, F., Einenkel, J., Hoeckel, M., & von Knebel Doeberitz, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206629 · Cited by 167
Luft, F., Klaes, R., Nees, M., Dürst, M., Heilmann, V., Melsheimer, P., & Doeberitz, M. V. K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200102)9999:9999<::aid-ijc1144>3.0.co;2-l · Cited by 166
Winer, R. L., Hughes, J. P., Feng, Q., Xi, L. F., Cherne, S., O'Reilly, S., Kiviat, N. B., & Koutsky, L. A. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1108 · Cited by 166
Gardasil-9: A global survey of projected efficacy
Zhai, L., & Tumban, E. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.03.016 · Cited by 165
Epigenetics and Genetics of Viral Latency
Lieberman, P. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.04.008 · Cited by 165
Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3
Wentzensen, N., Sun, C., Ghosh, A., Kinney, W., Mirabello, L., Wacholder, S., Shaber, R., LaMere, B., Clarke, M., Lorincz, A. T., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs425 · Cited by 160
Méndez, F., Muñoz, N., Posso, H., Molano, M., Moreno, V., van den Brule, A. J. C., Ronderos, M., Meijer, C., Muñoz, Á., & Instituto Nacional de Cancerología Human Papillomavirus Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/444391 · Cited by 160
Chen, Y., Yao, H., Thompson, E. J., Tannir, N. M., Weinstein, J. N., & Su, X. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts665 · Cited by 158
Awady, M. K. E., Kaplan, J., O’Brien, S. J., & Burk, R. D. (1987) · Virology · doi:10.1016/0042-6822(87)90478-8 · Cited by 154
Human Papillomavirus E7 Oncoproteins Bind a Single Form of Cyclin E in a Complex with cdk2 and p107
McIntyre, M., Ruesch, M. N., & Laimins, L. A. (1996) · Virology · doi:10.1006/viro.1996.0008 · Cited by 151
Hesselink, A. T., Heideman, D. A. M., Steenbergen, R. D. M., Coupé, V. M. H., Overmeer, R. M., Rijkaart, D., Berkhof, J. H., Meijer, C. J. L. M., & Snijders, P. J. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2548 · Cited by 150
Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy
Smola, S. (2017) · Viruses · doi:10.3390/v9090254 · Cited by 143
Shi, Y., Li, L., Hu, Z.-B., Li, S., Wang, S.-X., Liu, J., Wu, C., He, L., Zhou, J.-F., Li, Z.-Q., et al. (2013) · Nature Genetics · doi:10.1038/ng.2687 · Cited by 142
Self-citationHPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53
Kwok (2010) · Oncology Reports · doi:10.3892/or_00001023 · Cited by 140
Wentzensen, N., Ridder, R., Klaes, R., Vinokurova, S., Schaefer, U., & Doeberitz, M. V. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205104 · Cited by 139
Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
Poljak, M., Kocjan, B. J., Oštrbenk, A., & Seme, K. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.10.023 · Cited by 133
Mirabello, L. J., Sun, C., Ghosh, A., Rodríguez, A. C., SCHIFFMAN, M. H., Wentzensen, N., Hildesheim, A., Herrero, R., Wacholder, S., Lorincz, A. T., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs135 · Cited by 132
Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide
Chen, A. A., Gheit, T., Franceschi, S., Tommasino, M., & Clifford, G. M. (2015) · Journal of Virology · doi:10.1128/jvi.01747-15 · Cited by 130
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Hu, Z., Ding, W., Zhu, D., Yu, L., Jiang, X., Wang, X., Zhang, C., Wang, L., Ji, T., Liu, D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci78206 · Cited by 130
Self-citationHäfner, N., Driesch, C., Gajda, M. R., Jansen, L., Kirchmayr, R., Runnebaum, I. B., & Dürst, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210791 · Cited by 126
Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas
Xu, B., Chotewutmontri, S., Wolf, S., Klos, U., Schmitz, M., Dürst, M., & Schwarz, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066693 · Cited by 126
Olthof, N. C., Huebbers, C. U., Kolligs, J., Henfling, M. E. R., Ramaekers, F. C. S., Cornet, I., Albrechts, J. C. M., Stegmann, A. P. A., Silling, S., Wieland, U., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29112 · Cited by 120
Bray, F., Jemal, A., Torre, L. A., Forman, D., & Vineis, P. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv273 · Cited by 120
Arroyo, M., Bagchi, S., & Raychaudhuri, P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6537 · Cited by 119
Practice Bulletin No. 157: Cervical Cancer Screening and Prevention
(2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001263 · Cited by 118
Bierkens, M., Hesselink, A. T., Meijer, C. J. L. M., Heideman, D. A. M., Wisman, G. B. A., van der Zee, A. G. J., Snijders, P. J. F., & Steenbergen, R. D. M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28138 · Cited by 117
Mechanistic signatures of HPV insertions in cervical carcinomas
Holmes, A. M., Lameiras, S., Jeannot, E., Marie, Y., Castéra, L., Sastre‐Garau, X., & Nicolas, A. G. (2016) · npj Genomic Medicine · doi:10.1038/npjgenmed.2016.4 · Cited by 117
MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors
Peter, M., Rosty, C., Couturier, J., Radvanyi, F., Teshima, H., & Sastre-Garau, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209625 · Cited by 114
Pandey, S., Mittal, R. D., Srivastava, M., Srivastava, K., Singh, S., Srivastava, S., & Mittal, B. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.032 · Cited by 114
Association between HLA‐DQB1 alleles and risk for cervical cancer in African‐American women
Grégoire, L., Lawrence, W. D., Kukuruga, D. L., Eisenbrey, A. B., & Lancaster, W. D. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570411 · Cited by 107
HPV Infection in Women: Psychosexual Impact of Genital Warts and Intraepithelial Lesions
Graziottin, A., & Serafini, A. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01151.x · Cited by 104
Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus
Kim, J. J., Burger, E. A., Sy, S., & Campos, N. G. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw216 · Cited by 104
The role of viral integration in the development of cervical cancer
Yu, T., Ferber, M. J., Cheung, T. H., Chung, T. K. H., Wong, Y. F., & Smith, D. I. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.08.021 · Cited by 102
Dall, K. L., Scarpini, C. G., Roberts, I., Winder, D. M., Stanley, M., Muralidhar, B., Herdman, M. T., Pett, M. R., & Coleman, N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1741 · Cited by 100
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases
Skeate, J. G., Woodham, A. W., Einstein, M. H., Silva, D. M. D., & Kast, W. M. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1136039 · Cited by 100
Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma
Peter, M., Stransky, N., Couturier, J., Hupé, P., Barillot, E., de Crémoux, P., Cottu, P. H., Radvanyi, F., & Sastre‐Garau, X. (2010) · The Journal of Pathology · doi:10.1002/path.2713 · Cited by 97
Dai, J., Shen, W., Wen, W., Chang, J., Wang, T., Chen, H., Jin, G., Ma, H., Wu, C. H., Li, L., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30447 · Cited by 92
Self-citationChristiansen, I. K., Driesch, C., Vinokurova, S., Hovig, E. J., Schneider, A., Doeberitz, M. V. K., & Dürst, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2776 · Cited by 87
Brink, A. A. T. P., Snijders, P. J. F., & Meijer, C. J. L. M. (2007) · Disease Markers · doi:10.1155/2007/147429 · Cited by 85
Methylation of the long control region of HPV16 is related to the severity of cervical neoplasia
Ding, D., Chiang, M., Lai, H., Hsiung, C. A., Hsieh, C., & Chu, T. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.08.023 · Cited by 82
Human papillomavirus genotyping by 454 next generation sequencing technology
Barzon, L., Militello, V., Lavezzo, E., Franchin, E., Peta, E., Squarzon, L., Trevisan, M., Pagni, S., Bello, F. D., Toppo, S., et al. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.07.006 · Cited by 79
Metagenomic sequencing of “HPV-negative” condylomas detects novel putative HPV types
Johansson, H., Bzhalava, D., Ekström, J., Hultin, E., Dillner, J., & Forslund, O. (2013) · Virology · doi:10.1016/j.virol.2013.01.023 · Cited by 78
Su, P.-H., Lin, Y.-W., Huang, R.-L., Liao, Y.-P., Lee, H.-Y., Wang, H.-C., Chao, T.-K., Chen, C.-K., Chan, M. W. Y., Chu, T.-Y., et al. (2012) · Oncogene · doi:10.1038/onc.2012.29 · Cited by 75
Structural mutations in cancer: mechanistic and functional insights
Inaki, K., & Liu, E. T. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.07.002 · Cited by 75
Loss of gene function as a consequence of human papillomavirus DNA integration
Schmitz, M., Driesch, C., Beer‐Grondke, K., Jansen, L., Runnebaum, I. B., & Dürst, M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27433 · Cited by 75
Analytical characterization of the APTIMA® HPV Assay
Dockter, J., Schröder, A., Eaton, B., Wang, A., Sikhamsay, N., Morales, L., & Giachetti, C. (2009) · Journal of Clinical Virology · doi:10.1016/s1386-6532(09)70007-1 · Cited by 75
Li, J., Wan, R., Yu, A. C.-S., Co, N. N., Wong, N., & Chan, T. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt011 · Cited by 73
Chandrani, P., Kulkarni, V., Iyer, P. S., Upadhyay, P., Chaubal, R., Das, P. K., Mulherkar, R., Singh, R. K. B., & Dutt, A. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.121 · Cited by 72
Cervical cancer screening: which HPV test should be used—L1 or E6/E7?
Tjalma, W. A. A., & Depuydt, C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.06.027 · Cited by 72
Yu, M., TONG, J. H. M., Chan, P. K. S., Lee, T., Chan, M. W. Y., Chan, A. W. H., Lo, K. W., & To, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11051 · Cited by 71
Frumovitz, M., Burzawa, J. K., Byers, L. A., Lyons, Y. A., Ramalingam, P., Coleman, R. L., & Brown, J. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.04.001 · Cited by 71
Zhang, R., Shen, C., Zhao, L., Wang, J., McCrae, M. A., Chen, X., & Lu, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29872 · Cited by 70
Tornesello, M. L., Annunziata, C., Buonaguro, L., Losito, S., Greggi, S., & Buonaguro, L. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0255-5 · Cited by 68
Clinical Performance of Roche Cobas 4800 HPV Test
Cui, M., Chan, N., Liu, M., Thai, K. K., Malaczynska, J., Singh, I. R., Zhang, D., & Ye, F. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00883-14 · Cited by 68
Evidence that instability within the FRA3B region extends four megabases
Becker, N. A., Thorland, E. C., Denison, S. R., Phillips, L. A., & Smith, D. I. (2002) · Oncogene · doi:10.1038/sj.onc.1205950 · Cited by 66
Rossi, P. G., Carozzi, F., Federici, A., Ronco, G., Zappa, M., Franceschi, S., Barca, A., Barzon, L., Baussano, I., Berliri, C., et al. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.11.020 · Cited by 66
Association Between HLA DQBl * 03 and Cervical Intra-epithelial Neoplasia
Odunsi, K. O., Terry, G., Ho, L., Bell, J. I., Cuzick, J. M., & Ganesan, T. S. (1995) · Molecular Medicine · doi:10.1007/bf03401564 · Cited by 65
Frenel, J., Tourneau, C. L., O’Neil, B. H., Ott, P. A., Piha-Paul, S. A., Gomez‐Roca, C., van Brummelen, E. M. J., Rugo, H. S., Thomas, S., Saraf, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.5515 · Cited by 60
Spaans, V. M., Trietsch, M. D., Peters, A. A. W., Osse, M., ter Haar, N. T., Fleuren, G. J., & Jordanova, E. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133670 · Cited by 58
Ginocchio, C. C., Barth, D., & Zhang, F. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.01824-07 · Cited by 58
Lando, M., Fjeldbo, C. S., Wilting, S. M., et al. (2015) · Epigenetics · doi:10.1080/15592294.2015.1085140 · Cited by 57
Ho, D. W., Sze, K. M., & Ng, I. O. (2015) · Oncotarget · doi:10.18632/oncotarget.4187 · Cited by 56
van Baars, R., van der Marel, J., Snijders, P. J. F., Rodríguez-Manfredi, Á., ter Harmsel, B., van den Munckhof, H. A. M., Ordï, J., Pino, M. L. D., van de Sandt, M. M., Wentzensen, N., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29706 · Cited by 55
Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
Xiang, L., Li, J., Jiang, W., Shen, X., Yang, W., Wu, X., & Yang, H. (2014) · Oncotarget · doi:10.18632/oncotarget.3212 · Cited by 54
HPV Genotyping and Site of Viral Integration in Cervical Cancers in Indian Women
Das, P. K., Thomas, A., Mahantshetty, U. M., Shrivastava, S. K., Deodhar, K., & Mulherkar, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041012 · Cited by 52
Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population
Hang, D., Yin, Y., Han, J., Jiang, J., Ma, H., Xie, S., Feng, X., Zhang, K., Hu, Z., Shen, H., et al. (2015) · Virology · doi:10.1016/j.virol.2015.11.016 · Cited by 52
Self-citationIs precision medicine the route to a healthy world?
Coote, J. H., & Joyner, M. J. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60786-3 · Cited by 52
Gao, G., Johnson, S. H., Kasperbauer, J. L., Eckloff, B. W., Tombers, N. M., Vasmatzis, G., & Smith, D. I. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.12.006 · Cited by 49
Ameur, A., Meiring, T. L., Bunikis, I., Häggqvist, S., Lindau, C., Lindberg, J. H., Gustavsson, I. M., Mbulawa, Z. Z. A., Williamson, A., & Gyllensten, U. B. (2014) · Scientific Reports · doi:10.1038/srep04398 · Cited by 48
TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas
Vinothkumar, V., Arunkumar, G., Revathidevi, S., Arun, K., Manikandan, M., Rao, A. K. D. M., Seenivasagam, R. K., Ajay, C., Rajaraman, R., Ramani, R., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4694-2 · Cited by 47
Förster, M., Szymczak, S., Ellinghaus, D., Hemmrich, G., Rühlemann, M. C., Kraemer, L., Mucha, S., Wienbrandt, L., Stanulla, M., & Franke, A. (2015) · Scientific Reports · doi:10.1038/srep11534 · Cited by 43
Genetic profiles of cervical tumors by high‐throughput sequencing for personalized medical care
Müller, E., Brault, B., Holmes, A. M., Legros, A., Jeannot, E., Campitelli, M., Rousselin, A., Goardon, N., Frébourg, T., Krieger, S., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.492 · Cited by 42
Designing a High-Throughput Somatic Mutation Profiling Panel Specifically for Gynaecological Cancers
Spaans, V. M., Trietsch, M. D., Crobach, S., Stelloo, E., Kremer, D., Osse, E. M., ter Haar, N. T., van Eijk, R., Muller, S., van Wezel, T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093451 · Cited by 42
Helland, Å., Børresen‐Dale, A., Kristensen, G. B., & Rønningen, K. S. (1994) · PubMed · Cited by 41
Gimenes, F., Teixeira, J. J. V., de Abreu, A. L. P., Souza, R. P., Pereira, M. W., da Silva, V. R. S., Bôer, C. G., Maria–Engler, S. S., Bonini, M. G., Borelli, S. D., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.004 · Cited by 40
Marco, L. D., Gillio‐Tos, A., Bonello, L., Ghisetti, V., Ronco, G., & Merletti, F. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.09.008 · Cited by 39
Somatic mutation in PIK3CA is a late event in cervical carcinogenesis
Verlaat, W., Snijders, P. J. F., van Moorsel, M. I. H., Bleeker, M. C. G., Rozendaal, L., Sie, D., Ylstra, B., Meijer, C. J. L. M., Steenbergen, R. D. M., & Heideman, D. A. M. (2015) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.27 · Cited by 37
Schutzbank, T. E., Jarvis, C. D., Kahmann, N., Lopez, K., Weimer, M., & Yount, A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01833-07 · Cited by 35
Yin, F., Wang, N., Bi, X., Yu, X., Xu, X., Wang, Y.-L., Zhao, C., Luo, B., & Wang, Y. (2016) · Virology Journal · doi:10.1186/s12985-016-0515-5 · Cited by 35
Immunizing against Anogenital Cancer: HPV Vaccines
Pogoda, C. S., Roden, R. B. S., & Garcea, R. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005587 · Cited by 33
Tanaka, H., Kanda, M., Koike, M., Iwata, N., Shimizu, D., Ezaka, K., Sueoka, S., Tanaka, Y., Takami, H., Hashimoto, R., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3167 · Cited by 31
Климов, Е. А., Vinokurova, S., Мойсяк, Е. В., Rakhmanaliev, E., Kobseva, V., Laimins, L. A., Kisseljov, F. L., & Сулимова, Г. Е. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-24 · Cited by 30
Li, L., Xu, C., Long, J., Shen, D., Zhou, W., Zhou, Q., Yang, J. Y., & Jiang, M. (2015) · Oncotarget · doi:10.18632/oncotarget.4525 · Cited by 30
Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain
Pérez‐Castro, S., Cid, A., Iñarrea, A., Mosquera, M. P., Lamas, M. J., Couso, B., Gil, M. T., Álvarez, M. J., Rey, S., López-Miragaya, I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104678 · Cited by 30
Ivansson, E. L., Juko‐Pecirep, I., Erlich, H. A., & Gyllensten, U. B. (2011) · Genes and Immunity · doi:10.1038/gene.2011.40 · Cited by 28
Roszak, A., Lianeri, M., Sowińska, A., & Jagodziński, P. P. (2014) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-014-0095-2 · Cited by 27
Stillman, M. J., Day, S. P., & Schutzbank, T. E. (2009) · Journal of Clinical Virology · doi:10.1016/s1386-6532(09)70011-3 · Cited by 26
Chakraborty, C., Dutta, S., Mukherjee, N., Samadder, S., Roychowdhury, A., Roy, A. K., Mondal, R. K., Basu, P. S., Roychoudhury, S., & Panda, C. K. (2014) · Tumor Biology · doi:10.1007/s13277-014-2707-1 · Cited by 26
Periwal, V. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw052 · Cited by 25
Accurate human papillomavirus genotyping by 454 pyrosequencing
Militello, V., Lavezzo, E., Costanzi, G., Franchin, E., Camillo, B. D., Toppo, S., Palù, G., & Barzon, L. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12219 · Cited by 24
Sauter, J. L., Mount, S. L., John, T. L. S., Wojewoda, C. M., Bryant, R. J., & Leiman, G. (2014) · Acta Cytologica · doi:10.1159/000358246 · Cited by 24
Liu, P., Iden, M., Fye, S., Huang, Y., Hopp, E. E., Chen, C., Lü, Y., & Rader, J. S. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0368 · Cited by 24
Adverse outcomes after colposcopy
Flanagan, S., Wilson, S., Luesley, D. M., Damery, S. L., & Greenfield, S. (2011) · BMC Women s Health · doi:10.1186/1472-6874-11-2 · Cited by 23
D’Cruz, O. J., Samuel, P., Waurzyniak, B. J., & Uckun, F. M. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.103.019182 · Cited by 22
Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomes
Galván, S. C., Martínez-Salazar, M., Galván, V. M., Méndez‐Martínez, R., Díaz-Contreras, G. T., Alvarado-Hermida, M., Alcántara-Silva, R., & García-Carrancá, A. M. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-580 · Cited by 20
Localized delivery of chemotherapy to the cervix for radiosensitization
Hodge, L. S., Downs, L. S., Chura, J. C., Thomas, S. G., Callery, P. S., Soisson, A. P., Kramer, P., Wolfe, S. S., & Tracy, T. S. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.07.097 · Cited by 20
Alterations of RASSF1A in premalignant cervical lesions: Clinical and prognostic significance
Mitra, S., Mazumder, D. I., Basu, P. S., Mondal, R. K., Roy, A. K., Roychoudhury, S., & Panda, C. K. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20837 · Cited by 19
Allelic Loss of 10q23.3, the PTEN Gene Locus in Cervical Carcinoma from Northern Indian Population
Rizvi, M. M. A., Alam, M., Mehdi, S. J., Ali, A., & Batra, S. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9446-z · Cited by 19
Baltzer, N., Sundström, K., Nygård, J. F., Dillner, J., & Komorowski, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30725 · Cited by 19
Mitochondrial DNA mutations in patients with HRHPV-related cervical lesions.
Goia-Ruşanu, C. D., Iancu, I. V., Botezatu, A., Socolov, D. G., Huică, I., Pleşa, A., & Anton, G. (2011) · PubMed · Cited by 17
Frimer, M., Sun, C., McAndrew, T., Smith, B., Harari, A., Chen, Z., Mirabello, L. J., Wentzensen, N., Goldberg, G. L., Rodríguez, A. C., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.05.001 · Cited by 16
Jia, M., Han, J., Hang, D., Jiang, J., Wang, M., Wei, B., Dai, J., Zhang, K., Guo, L., Qi, J., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4673-7 · Cited by 16
Self-citationHamdani, W. E., Amrani, M., Attaleb, M., Laantri, N., Ennaji, M. M., Khyatti, M., & Mzibri, M. E. (2010) · PubMed · doi:10.1170/157 · Cited by 13
Levin, C., Sharma, M., Olson, Z. D., Verguet, S., Shi, J., Wang, S., Qiao, Y., Jamison, D. T. T., & Kim, J. J. (2015) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-0349-9_ch18 · Cited by 9
(2000) · PubMed
Metadata
- Authors
- Hu, Z., & Ma, D.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2018-09-14
- Volume
- 7
- Issue
- 10
- Pages
- 5217-5236
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2891836094
- Cited by
- 338
- References
- 171
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.